TickerFactsScreenerDevelopers

Eloxx Pharmaceuticals, Inc. (ELOX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

1998: $02009: $380.6K2010: $8.03M2011: $3.61M2012: $2.00M2013: $1.60M2014: $1.74M2015: $1.37M2016: $2.21M2017: $24.05M2018: $48.61M2019: $22.49M2020: $24.67M2021: $42.27M2022: $19.21M2023: $1.13M2024: $111.0K2025: $4.79M$4.79M
1998Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$4.79M+4210.8%
2024$111.0K-90.2%
2023$1.13M-94.1%
2022$19.21M-54.6%
2021$42.27M+71.3%
2020$24.67M+9.7%
2019$22.49M-53.7%
2018$48.61M+102.1%
2017$24.05M+987.2%
2016$2.21M+61.5%
2015$1.37M-21.1%
2014$1.74M+8.4%
2013$1.60M-19.9%
2012$2.00M-44.6%
2011$3.61M-55.0%
2010$8.03M+2009.0%
2009$380.6K—
1998$0—